SEC Form D · Amendment · filed March 29, 2019
LifeMine Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Yanling L. Cao · Cambridge, MADirectorGregory L. Verdine · Cambridge, MAExec · DirectorWei L. Li · Cambridge, MADirectorKaiwalya Kher · San Francisco, CADirectorJonathan N. Abe · CAMBRIDGE, MAExec · DirectorRichard L. Klausner · Cambridge, MADirectorTravis J. Putnam · Los Angeles, CAExecMichael Bach · San Francisco, CADirectorWei L. Li · Cambridge, MADirectorKrishna L. Yeshwant · Cambridge, MADirectorOmar N. Blayton · CAMBRIDGE, MADirectorRich Levandov · San Francisco, CAExecWeiqing L. Zhou · Cambridge, MAExecBrady Bohrmann · San Francisco, CAExec · DirectorRichard L. Klausner · Cambridge, MADirectorHelen Thornton · Hamilton, BermudaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗